Please ensure Javascript is enabled for purposes of website accessibility

VIDEO: A Little Caution | Cabot Weekly Review

Mike Cintolo shares all his thoughts on the market’s historic crash, including some scenarios that are possible going forward.

In today’s Weekly Video small cap analyst Tyler Laundon talks about why he’s getting a little more cautious on high-growth tech and MedTech stocks after a flurry of earnings reports sent several of these companies to new all-time highs. Tyler revisits a number of companies he highlighted on April 10 and which are up an average of 34% since. Stocks discussed include FIVN, RGEN, LVGO, FVRR, CDLX and SVMK.

Get It While It’s Hot!

Be among the first to see the Cabot Weekly Review when it comes out. Have it delivered right to your inbox every Saturday. Get on the list:

[form src='/form/cabot-weekly-review’]
Along with your weekend video, you will receive our free weekday advisory, Cabot Wealth Daily, with top stock picks, market news and insightful commentary from our analysts.


Tyler Laundon is chief analyst of the limited-subscription advisory, Cabot Small-Cap Confidential and grand slam advisory Cabot Early Opportunities. He has spent his entire career managing, consulting and analyzing start-up and small-cap companies. His hands-on experience has taught Tyler that the development of a superior business model is the biggest factor in determining a company’s long-term success. Accordingly, his research focuses on assessing the viability of management’s growth strategies, trends in addressable markets and achievement of major developmental milestones.